Hideo Umeuchi

Optimal dose determination of enerisant (TS-091) for patients with narcolepsy: two randomized, double-blind, placebo-controlled trials

M. Uchiyama, N. Uchimura, Y. Inoue, 2022, BMC Psychiatry.

Using the drug repositioning approach to develop a novel therapy, tipepidine hibenzate sustained-release tablet (TS-141), for children and adolescents with attention-deficit/hyperactivity disorder

T. Okada, A. Tomoda, Takuya Saito, 2020, BMC Psychiatry.

Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled study.

M. Fava, C. Nemeroff, S. Chaki, 2020, Journal of psychiatric research.